Transcriptome and metabolome sequencing identifies glutamate and LPAR1 as potential factors of anlotinib resistance in thyroid cancer.
| Autor: | Bin Liu, Ying Peng, Yanjun Su, Chang Diao, Jun Qian, Xiangxiang Zhan, Ruochuan Cheng |
|---|---|
| Zdroj: | Anti-Cancer Drugs; Sep2024, Vol. 35 Issue 8, p741-751, 11p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|